ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2196

Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study

Christina H. Opava1, Annika Björk2, Alyssa B. Dufour1,3, Birgitta Nordgren1 and Ingrid Demmelmaier4, 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, 2Nacka Rehabilitation Center, Stockholm County Council, Nacka, Sweden, 3Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, 4Neurobiology, Care Sciences & Society, Karolinska Institutet, Huddinge, Sweden

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: longitudinal studies, Pain and physical activity

Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - ARHP Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Trajectories and Predictors of Fear-Avoidance in Persons With Rheumatoid Arthritis. A Longitudinal Observational Study

 

Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease with symptoms such as pain, severe fatigue, depression and activity limitation. Pain and activity limitation are known to increase the risk of developing fear-avoidance behavior but their associations with physical activity are not fully verified. RA is a chronic disease that people have to live with for many years but knowledge on how fear-avoidance develops over time is still scarce. The aim of the study was to identify and describe groups with different trajectories of fear-avoidance beliefs over 2 years and to identify predictors for each trajectory in people with RA.

Methods: A sample of 2569 people with RA (mean age 58, 77% women) was identified via the Swedish Rheumatology Quality Registers. They responded, at baseline and at 1-year and 2-year follow-ups, to a valid questionnaire on demographics (age, gender, number of children and adults in household, education, income) health-enhancing physical activity (HEPA, current and maintained), disease-related factors (co-morbidity, perceived health, pain, fatigue, activity limitation) and psychosocial matters (fear-avoidance beliefs, anxiety/depression and self-efficacy for exercise). Data were analyzed with k-means longitudinal cluster analysis to identify trajectories of fear-avoidance beliefs and multinomial logistic regression to identify predictors of each trajectory.  

Results: Three stable trajectories of fear-avoidance beliefs were identified from the cluster analysis; one with low (n = 1060) fear-avoidance beliefs, one with moderate (n = 1043) and one with high (n = 466). Predictors of stable high fear-avoidance beliefs, compared to low or moderate levels, were male gender, below average income, current physical activity below HEPA levels and high activity limitation. Additional predictors of high fear-avoidance beliefs compared to low were below-university education, high pain, moderate activity limitation and low self-efficacy for exercise (Table 1).

Conclusion: There are 3 stable trajectories of fear-avoidance behavior in people with RA. The strongest modifiable predictors of persistently high fear-avoidance beliefs are more pronounced activity limitation, pain, below HEPA levels and low self-efficacy for exercise. These factors are important to identify at an early stage in people with RA in order to develop strategies to prevent high fear-avoidance behavior. Table 1. Baseline predictors of trajectories with high (n = 466) vs low (n = 1060) and moderate (n = 1043) fear/avoidance beliefs. Odds ratios (OR) and 95% confidence intervals (CI). Bold figures indicate significant predictors (p < 0.01).  

Baseline predictors  

High vs low

OR (95% CI)

High vs moderate

OR (95% CI)

  Gender Women vs men

 

0.30 (0.22-0.41)

 

0.51 (0.39-0.67)

 

Education High school vs university

1.84 (1.29-2.62)

1.33 (0.96-1.85)

 

  Elementary school vs university  

1.99 (1.38-2.86)

1.34 (0.96-1.87)

Income Above vs below average

0.42 (0.31-0.57)

0.50 (0.38-0.65)

 

Current HEPA Yes vs no

0.54 (0.41-0.72)

0.70  (0.55-0.89)

 

Pain (VAS, 0-100)a >55 vs <30

2.58 (1.58-4.22)

1.22 (0.79-1.87)

 

Activity limitationa (HAQ, 0-3) >1.0 vs 0

7.14 (4.19-12.19)

2.11 (1.28-3.47)

  0.1-1.0 vs 0  

3.10 (2.01-4.78)

1.60 (1.04-2.48)

Anxiety/depression (EuroQoL, yes/some/no)   Some vs no

1.50 (1.13-2.01)

1.31 (1.01-1.69)

 

Self-efficacy for exercise (ESES, 6-60)a   Highest tertile vs lowest tertile

0.53 (0.38-0.76)

0.87 (0.63-1.19)

aHigh values indicate worse health HEPA = Health-enhancing physical activity VAS = Visual analogue scale HAQ = Stanford Health Assessment Questionnaire EuroQoL = Euro quality of life ESES = Exercise self-efficacy scale  


Disclosure: C. H. Opava, None; A. Björk, None; A. B. Dufour, None; B. Nordgren, None; I. Demmelmaier, None.

To cite this abstract in AMA style:

Opava CH, Björk A, Dufour AB, Nordgren B, Demmelmaier I. Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/trajectories-and-predictors-of-fear-avoidance-in-persons-with-rheumatoid-arthritis-a-longitudinal-observational-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trajectories-and-predictors-of-fear-avoidance-in-persons-with-rheumatoid-arthritis-a-longitudinal-observational-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology